First human test of new drug SPY001-001 begins
Knowledge-focused
Completed
This early-stage study tested the safety and tolerability of a new drug called SPY001-001 in 96 healthy adults. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moves through the body. The goal was to gather safety in…
Phase: PHASE1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC